Mostrar el registro sencillo del ítem

In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest

dc.contributor.authorTorres-Narbona, Marta
dc.contributor.authorGuinea, Jesus
dc.contributor.authorMartinez-Alarcon, Jose
dc.contributor.authorPelaez, Teresa
dc.contributor.authorBouza, Emilio
dc.date.accessioned2024-02-06T15:25:45Z
dc.date.available2024-02-06T15:25:45Z
dc.date.issued2007-03-01
dc.identifier.citationTorres-Narbona, M., Guinea, J., Martínez-Alarcón, J., Peláez, T., & Bouza, E. (2007). In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrobial agents and chemotherapy, 51(3), 1126–1129. https://doi.org/10.1128/AAC.01539-06es
dc.identifier.issn0066-4804
dc.identifier.otherhttps://journals.asm.org/journal/aaces
dc.identifier.urihttp://hdl.handle.net/20.500.12020/1283
dc.description.abstractWe evaluated the activities of amphotericin B, itraconazole, voriconazole, caspofungin, and posaconazole against zygomycetes by CLSI M38-A, Etest and Sensititre. The most active drug was posaconazole, followed by amphotericin B and itraconazole. The correlation of the Etest and Sensititre with CLSI M38-A was moderate for posaconazole but poor for the others.es
dc.language.isoenes
dc.publisherAmerican Society for Microbiologyes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleIn Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etestes
dc.typearticlees
dc.identifier.doi10.1128/AAC.01539-06
dc.issue.number3es
dc.journal.titleAntimicrobial Agents and Chemotherapyes
dc.page.initial1126es
dc.page.final1129es
dc.relation.projectIDThis study was partially financed by grants from Red Espan˜ola de Investigacio´n en Patologı´a Infecciosa C/03/14 (REIPI). J.G. is contracted by Fondo de Investigacio´n Sanitaria (FIS) CM05/00171.es
dc.rights.accessRightsembargoedAccesses
dc.subject.areaCiencias Biomédicases
dc.subject.keywordStem-Cell transplantes
dc.subject.keywordBreak-through zygomycosises
dc.subject.keywordPulmonary zygomycosises
dc.subject.keywordSalvage therapyes
dc.subject.keywordLipid complexes
dc.subject.keywordDeep mycoseses
dc.subject.keywordMucormycosises
dc.subject.keywordRecipientses
dc.subject.keywordDiseasees
dc.subject.keywordSusceptibilitieses
dc.subject.unesco3201.03 Microbiología Clínicaes
dc.volume.number51es


Ficheros en el ítem

Fichero/sTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional